SpeculatingStocks   UserStream  Reactions  Data  Stock Buzz  Market  Pre  AH  Technicals  ETFs  Articles  Picks  Compare Stocks  Portal  Buckets  Post  Join  ☰
Remember
Forgot Pass?
 
 
Watch for Reactions to Your Posts or React Below to Other's Posts. Discover Stocks and Market Data.
ACOR Stream, Posts, Sentiment, Activity ↘
 ARQL  AMFE  BVTK  ANDI  SBOT  GMGI
 

ACOR
 
 

ACOR (Acorda Therapeutics, Inc.) · Research · Financials · News · Comments · Reactions · React Anonymously to $ACOR, Now!

 
  $23.85   +0.35   +1.49%  

 

 
 

ACOR 'Buy' / 'Sell' Stats
 
Sentiment Over the Last:  
  10-Mins: B:0 S:0  
  1-Hour: B:0 S:0  
6-Hours: B:0 S:0
1-Day: B:0 S:0
3-Days: B:0 S:0
1-Week: B:0 S:0
and more... sign up.
More ACOR Social Data
 

ACOR in Data Terminal

  
Research ACOR /w Social & Financial Data on ACOR
 

Top Stories Today 51s

  




 

ACOR Stats
 

Followers: 0

 		 
 

'Buys': 0

 		 
 

'Sells': 0

 		 
 

Go to a Symbol Page
 
  Go to a User Profile
 
 

Follow ACOR on Pulse
 
Sign Up for SpeculatingStocks Pulse: A Social Network for Investors
 

Global Streams
 
PulseStream
SpecStream
UserStream
Reactions
EchoStream
 

Stock Data Terminal

  
Stock Market Data
  SpecStream Components
 
SpecStream Trending Stock Exchanges S&P Premarket Gainers & Losers Morning Earning Releases Futures After the Bell Earning Releases Technical Indicators ETF Movers Market Cap Milestones Current Movers - Gainers Current Movers - Decliners Headlines Media Buzz Economic News Top Stories Pulse User Buys Pulse User Sells B/S Today Pos. Sent. Milestones B/S Today Neg. Sent. Milestones Stock Follower Milestones Corporate Alerts Short Squeeze Alerts Price to Earnings PE Alerts Price to Sales PS Alerts Price to Book PB Alerts Insider Holding Alerts Institutional Holding Alerts Low Float Stocks Profitable or Not Cash Flow Positive High Beta Volatile Stocks Stocks Followed by Users
 
 

$ACOR Stream | Posts: · Avg/Day:

$ACOR Reactions		    

Acorda Therapeutics, Inc. ($ACOR)


Acorda Therapeutics, Inc. develops and markets therapeutic products for nervous system disorders. The company... More | Chart | Post
Profitable or Not
$ACOR (Acorda Therapeutics, Inc.) did not produce a profit last quarter with Quarterly Net Income of $(8.2M).
More than a wk ago | 0 buys, 0 sells
0
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+5
React Anonymously
Technical Indicators
Stocks with an Improving Chaikin Money Flow: $ABMD, $ABR, $ABT, $ACOR, $APTS, $ATO, $AXGN, $BABA, $BKHU, $BKLLF.
More than 2 wks ago | 0 buys, 0 sells
+1
React Anonymously
Morning Earning Releases
Earning Releases this morning: $DDD, $ACOR, $AHC, $ALE, $AMRN.
More than 2 wks ago | 0 buys, 0 sells
0
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+5
React Anonymously
+8
React Anonymously
High Beta Volatile Stocks
$ACOR (Acorda Therapeutics, Inc.) is significantly more volatile than the overall market with a Beta of 2.10.
More than 1 mo ago | 0 buys, 0 sells
0
React Anonymously
Institutional Holding Alerts
$ACOR (Acorda Therapeutics, Inc.) has significant institutional ownership of at least 20% with institutional ownership of 97.91%.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
Corporate Alerts
$ACOR Acorda Therapeutics submitted a MAA to the EMA for IBRIJA; PDUFA of October 5, 2018.
More than 1 mo ago | 0 buys, 0 sells
0
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+5
React Anonymously
Cash Flow Positive
$ACOR (Acorda Therapeutics, Inc.) is cash flow positive as of at least the last quarter with Quarterly Cash Flow of $114.92M.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
Institutional Holding Alerts
$ACOR (Acorda Therapeutics, Inc.) has significant institutional ownership of at least 20% with institutional ownership of 99.46%.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
SpecStream Trending
Stocks trending in the SpecStream: $UCTT, $RDNT, $AMLH, $GOPH, $ADTN, $ABUS, $LOCO, $VREX, $ACOR, $OTIV.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
After NASDAQ Gainers
Top after-hours gainers: *$INO ⇑ +8.28%, $UCTT ⇑ +3.59%, $RDNT ⇑ +2.90%, $LOCO ⇑ +2.18%, *$BGNE ⇑ +2.04%, *$CENX ⇑ +1.89% and $ACOR ⇑ +1.79%.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+5
React Anonymously
After NASDAQ Active
Most active after hours: *$ABUS +9.73%, *$UCTT +3.59%, *$RDNT +2.90%, *$LOCO +2.18%, *$VREX +2.18%, *$ADTN +1.85% and *$ACOR +1.79%.
More than 1 mo ago | 0 buys, 0 sells
+2
React Anonymously
After NASDAQ Gainers
Top after-hours gainers: *$ABUS ⇑ +9.73%, *$UCTT ⇑ +3.59%, *$RDNT ⇑ +2.90%, *$LOCO ⇑ +2.18%, *$VREX ⇑ +2.18%, *$ADTN ⇑ +1.85% and *$ACOR ⇑ +1.79%.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
High Beta Volatile Stocks
$ACOR (Acorda Therapeutics, Inc.) is significantly more volatile than the overall market with a Beta of 2.14.
More than 1 mo ago | 0 buys, 0 sells
0
React Anonymously
Institutional Holding Alerts
$ACOR (Acorda Therapeutics, Inc.) has significant institutional ownership of at least 20% with institutional ownership of 78.09%.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+5
React Anonymously
SpecStream Trending
Stocks trending in the SpecStream: $TTOO, $IPGP, $FORM, $BIVV, $ACOR, $SPGI, $AVAV, $GTLS, $BOJA, $RIGL.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
After NASDAQ Losers
Top after-hours losers: *$RUN ⇓ -9.69%, *$SPPI ⇓ -8.96%, *$RAVN ⇓ -7.72%, *$TTOO ⇓ -7.11%, *$LBTYA ⇓ -6.98%, *$GTLS ⇓ -5.99% and *$ACOR ⇓ -5.62%.
More than 1 mo ago | 0 buys, 0 sells
0
React Anonymously
After NASDAQ Losers
Top after-hours losers: $AVAV ⇓ -8.90%, $RUN ⇓ -7.81%, $RAVN ⇓ -7.72%, *$TTOO ⇓ -7.11%, $LBTYA ⇓ -6.98%, *$ACOR ⇓ -5.62% and *$RIGL ⇓ -5.17%.
More than 1 mo ago | 0 buys, 0 sells
0
React Anonymously
After NASDAQ Losers
Top after-hours losers: $AVAV ⇓ -8.90%, $RUN ⇓ -7.81%, $RAVN ⇓ -7.72%, $IDXX ⇓ -7.10%, $LBTYA ⇓ -6.98%, $TTOO ⇓ -6.30% and *$ACOR ⇓ -5.62%.
More than 1 mo ago | 0 buys, 0 sells
0
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+5
React Anonymously
SpecStream Trending
Stocks trending in the SpecStream: $ACOR, $CRON, $BKNG, $ENDP, $AABA, $STB, $QCOM, $AAXN, $MU, $ETSY.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously

 



Go to Reactions Related to ACOR!


Don't have a Free SpeculatingStocks Account? Feel free to Post Anonymously or Leave Your Comment Below on Acorda Therapeutics, Inc. (ACOR) with your FB Social Media Account:


 

Reactions Related to $ACOR · All Reactions Stream Live

  



Your reaction and other reactions to $ACOR pulses will show here!

Post a reaction by clicking the "React Anonymously" link in any of the pulse posts in the stream above. No account required.

Want to react with an account? Get a Free Account.
 
 

ACOR Sentiment Today (Since 7 AM ET)

 
 

0

 
 

Live ACOR Activity

 
Be the First Pulse User to Follow, 'Buy', or 'Sell' ACOR. Instant Access Now to Pulse.
  The Revolution in Speculation Continues... 21,778 symbol pages... 955 users... 1,168,255 pulses... not one unhappy user. Sign up now, free!

Newest SpeculatingStocks Pulse User 

Nsirris
  403 Crowdsourced Stock Ratings Inside...
 

ACOR Snapshot · Research ACOR

 
 

ACOR

  (More Inside)      
  Volume: 59,844  
  Market Cap: $1.11B  
  Exchange: Nasdaq  
  Website: http://www.acorda.com  
  More ACOR Metrics  
 
 
  
   
   
  Industry: Health Care/Life Sciences  
  Acorda Therapeutics, Inc. develops and markets therapeutic products for nervous system disorders. The company's two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex...  
 
More ACOR Corporate Data 		 
 

ACOR Buzz

 
 

Headlines for Acorda Therapeutics, Inc. (ACOR)

  
  Acorda Provides Financial and Pipeline Update for First Quarter 2018 Press Release 05/02/18  
  Acorda to Present New Data For INBRIJA(TM) (levodopa inhalation powder) at 70(th) American Academy of Neurology Annual Meeting Press Release 04/16/18  
  Acorda First Quarter Update: Webcast/Conference Call Scheduled for May 2, 2018 Press Release 04/11/18  
  Acorda Files Marketing Authorization Application for INBRIJA(TM) (levodopa inhalation powder) Press Release 03/26/18  
  Acorda Rallies Parkinson's Community in First-of-Its-Kind Initiative to Foster Better Conversations About Parkinson's Symptoms Press Release 03/14/18  
 


News Headlines for Acorda Therapeutics, Inc. (ACOR)